Let's start with a little background
Very high GHK-Cu doses (10+ mg) don't produce proportionally greater effects than moderate doses (3-5mg)
A1C reduction ranges from 0.6% to 1.5%, depending on dose and baseline glucose levels
Adiposity is an independent risk factor for glycometabolism disorder, since fat accumulation affects insulins action by different mechanisms including insulin resistance in organs such as the liver and muscle tissue (46, 48)
Its triple-agonist mechanism targeting GLP-1, GIP, and glucagon simultaneously is genuinely novel, and the liver fat reduction data (82% at 24 weeks, per Sanyal et al., Nature Medicine 2024) is in a class of its own
Oxidative reactions in the tear fluid of patients suffering from dry eyes